Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Clements

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Vaccine|January 15, 2019
Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumoniaSarah M Baker, Derek Pociask, John D Clements, et al.
Infection and Immunity|April 25, 2012
The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigensElizabeth B Norton, Louise B Lawson, Zaid Mahdi, et al.
Neurobiology of Aging|December 10, 2002
Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvantsCynthia A Lemere, Edward T Spooner, Jodi F Leverone, et al.
Vaccine|April 23, 2003
Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting"Jodi F Leverone, Edward T Spooner, Herman K Lehman, et al.
British Journal of Clinical Pharmacology|May 20, 2011
Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activityForough Sanaee, John D Clements, Alistair W G Waugh, et al.
Vaccine|January 27, 2005
Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24GagSarah Leavell, Brittany Wright, Lori Scappino, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2011
Induction of increased permeability of polarized enterocyte monolayers by enterotoxigenic Escherichia coli heat-labile enterotoxinRoderick B Kreisberg, Jill Harper, Maura C Strauman, et al.
Infection and Immunity|February 18, 2016
Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coliArne M Taxt, Yuleima Diaz, Rein Aasland, et al.
Infection and Immunity|July 26, 2005
Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigensAudrey Glynn, Chad J Roy, Bradford S Powell, et al.
Journal of Virology|January 26, 2007
Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)Kristi L Smiley, Monica M McNeal, Mitali Basu, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Vaccine|January 15, 2019
Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumoniaSarah M Baker, Derek Pociask, John D Clements, et al.
Infection and Immunity|April 25, 2012
The A subunit of Escherichia coli heat-labile enterotoxin functions as a mucosal adjuvant and promotes IgG2a, IgA, and Th17 responses to vaccine antigensElizabeth B Norton, Louise B Lawson, Zaid Mahdi, et al.
Neurobiology of Aging|December 10, 2002
Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvantsCynthia A Lemere, Edward T Spooner, Jodi F Leverone, et al.
Vaccine|April 23, 2003
Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting"Jodi F Leverone, Edward T Spooner, Herman K Lehman, et al.
British Journal of Clinical Pharmacology|May 20, 2011
Drug-disease interaction: Crohn's disease elevates verapamil plasma concentrations but reduces response to the drug proportional to disease activityForough Sanaee, John D Clements, Alistair W G Waugh, et al.
Vaccine|January 27, 2005
Induction of serum and mucosal FIV-specific immune responses by intranasal immunization with p24GagSarah Leavell, Brittany Wright, Lori Scappino, et al.
The American Journal of Tropical Medicine and Hygiene|March 3, 2011
Induction of increased permeability of polarized enterocyte monolayers by enterotoxigenic Escherichia coli heat-labile enterotoxinRoderick B Kreisberg, Jill Harper, Maura C Strauman, et al.
Infection and Immunity|February 18, 2016
Towards Rational Design of a Toxoid Vaccine against the Heat-Stable Toxin of Escherichia coliArne M Taxt, Yuleima Diaz, Rein Aasland, et al.
Infection and Immunity|July 26, 2005
Protection against aerosolized Yersinia pestis challenge following homologous and heterologous prime-boost with recombinant plague antigensAudrey Glynn, Chad J Roy, Bradford S Powell, et al.
Journal of Virology|January 26, 2007
Association of gamma interferon and interleukin-17 production in intestinal CD4+ T cells with protection against rotavirus shedding in mice intranasally immunized with VP6 and the adjuvant LT(R192G)Kristi L Smiley, Monica M McNeal, Mitali Basu, et al.
Pageof 9